Latest Regulatory Compliance News

Gold Mountain Limited has issued nearly 486 million shortfall shares to underwriter Jose Luis Manzano, lifting its recent trading halt. A second tranche to Magnus Capital awaits shareholder approval, marking a pivotal step in the company’s capital raising.

The ACCC has issued a preliminary Statement of Issues regarding Elders Limited’s proposed acquisition of Delta Agribusiness, signaling potential competition challenges that could affect the deal’s timeline.

Careteq Limited faces a significant repayment demand from the ATO over R&D tax claims but is mounting a formal objection backed by legal counsel.

Select Harvests Limited has reported a remarkable turnaround with a $28.7 million profit in the first half of FY2025, buoyed by higher almond prices and improved operational efficiency. The company also secured $240 million in refinancing, positioning itself for future growth despite a slightly reduced almond crop forecast.

Select Harvests Limited has reported a remarkable turnaround with a $28.7 million net profit for the half-year ended March 2025, driven by higher almond prices and operational gains. The company forecasts a solid 2025 crop and has renewed a $240 million syndicated debt facility.

ASX has suspended trading of Magnum Mining’s MGUN securities following the abrupt cancellation of its entitlement offer, raising questions about the company’s capital strategy.

Inoviq Ltd’s shares have been suspended from trading on the ASX following a price query response, with the suspension to remain until the company meets listing rule requirements.

NoviqTech and Livium have partnered to digitise and tokenise the environmental benefits of battery recycling, aiming to enhance transparency and compliance in the critical minerals supply chain.

Magnum Mining’s recent entitlement offer attracted only 22% subscription, failing a key regulatory condition and rendering the offer void. The company now faces the challenge of securing alternative financing to maintain its strategic momentum.

Wellnex Life Limited’s shares have been suspended from trading on the ASX pending a response to regulatory queries, stirring investor uncertainty.

ALS Limited has announced a fully underwritten A$350 million equity placement to fund major upgrades to its global laboratory network and support future growth initiatives, aiming for mid single-digit EPS accretion by FY25 pro forma.

ALS Limited reported a 16% revenue increase to nearly $3 billion in FY2025, driven by acquisitions and organic growth, while underlying net profit after tax dipped slightly. The company announced a $350 million equity raise to fund expansion and sustainability initiatives.